TXMD
TherapeuticsMD, Inc.1.6200
-0.0800-4.71%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
18.75MP/E (TTM)
162.00Basic EPS (TTM)
0.01Dividend Yield
0%Recent Filings
8-K
8-K
Annual meeting results
TherapeuticsMD held its 2025 Annual Meeting on December 15, electing Tommy G. Thompson, Cooper C. Collins, Gail K. Naughton, and Justin Roberts to its board with over 98% support each. Shareholders ratified the auditor, approved executive pay and annual say-on-pay frequency, and boosted authorized common shares to 640 million (82% for). All four proposals passed decisively.
8-K
10-Q
Q3 FY2025 results
TherapeuticsMD posted Q3 license revenue of $784K, up 43% y/y from $547K yet flat q/q, driven by U.S. ($448K) and non-U.S. royalties; operating loss narrowed to $862K from $1,134K as G&A dipped slightly. Other income jumped to $912K on higher sublease and ANNOVERA royalties, flipping continuing ops to $50K profit. YTD revenue doubled to $2,129K, operating loss halved to $2,838K sans last year's impairments. Cash climbed to $7.1M with $2.1M operating inflow; no debt. Royalty receivables total $17.9M. Ongoing Mayne lawsuits cloud net working capital true-ups.
8-K
Q2 profit on royalty surge
TherapeuticsMD swung to a $545 thousand net income from continuing operations in Q2 2025, up from a $1.05 million loss last year, fueled by $1.0 million license revenue—mostly from Mayne—versus $234 thousand prior. Operating expenses plunged 45.5% to $1,647 thousand, sans last year's impairment. Cash sits at $6.1 million. Strategic alternatives hunt continues; no deal assured.
IPO
Employees
Sector
Industry
AMRX
Amneal Pharmaceuticals, Inc.
12.17-0.29
CPMD
Cannapharmarx Inc.
0.00-0.00
HIMS
Hims & Hers Health, Inc.
36.86+0.61
IMCC
IM Cannabis Corp.
1.73+0.21
INM
InMed Pharmaceuticals Inc.
1.31+0.12
MAJI
Marijuana Inc.
0.05-0.02
MRMD
MariMed Inc.
0.12+0.01
NXEN
Nexien BioPharma, Inc.
0.00+0.00
RAPH
RAPHAEL PHARMACEUTICAL INC
1.40+0.00
YCBD
cbdMD, Inc.
1.43+0.23